Mary Levin

682 total citations
14 papers, 508 citations indexed

About

Mary Levin is a scholar working on Surgery, Endocrinology, Diabetes and Metabolism and Urology. According to data from OpenAlex, Mary Levin has authored 14 papers receiving a total of 508 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Surgery, 5 papers in Endocrinology, Diabetes and Metabolism and 4 papers in Urology. Recurrent topics in Mary Levin's work include Bladder and Urothelial Cancer Treatments (5 papers), Urinary and Genital Oncology Studies (5 papers) and Thyroid Cancer Diagnosis and Treatment (5 papers). Mary Levin is often cited by papers focused on Bladder and Urothelial Cancer Treatments (5 papers), Urinary and Genital Oncology Studies (5 papers) and Thyroid Cancer Diagnosis and Treatment (5 papers). Mary Levin collaborates with scholars based in United States and Israel. Mary Levin's co-authors include Peggy Sullivan, Jianyu Rao, Max Perlman, J. Sunil Rao, Michael W. Yeh, Neda A. Moatamed, Masha J. Livhits, Katrina Beckett, Michael Douek and Angela M. Leung and has published in prestigious journals such as The Journal of Clinical Endocrinology & Metabolism, American Journal of Obstetrics and Gynecology and Surgery.

In The Last Decade

Mary Levin

13 papers receiving 484 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mary Levin United States	10	305	253	112	64	61	14	508
Hélio Bisi Brazil	13	156 0.5×	288 1.1×	85 0.8×	90 1.4×	31 0.5×	35	448
Nikola Knežević Croatia	12	201 0.7×	96 0.4×	29 0.3×	40 0.6×	128 2.1×	39	314
Arifa Pasic Netherlands	10	109 0.4×	148 0.6×	84 0.8×	236 3.7×	198 3.2×	11	451
Mojghan Amrikachi United States	8	222 0.7×	293 1.2×	118 1.1×	114 1.8×	66 1.1×	11	480
Jacques F. Bogdanowicz Netherlands	8	66 0.2×	61 0.2×	47 0.4×	83 1.3×	197 3.2×	15	355
Daniel P. Deklerk United States	7	110 0.4×	157 0.6×	26 0.2×	69 1.1×	309 5.1×	7	527
Gianfranco Mattarelli Switzerland	7	121 0.4×	18 0.1×	28 0.3×	69 1.1×	106 1.7×	10	272
Lucien Marchand France	12	123 0.4×	131 0.5×	158 1.4×	160 2.5×	17 0.3×	25	528
Sylvie Beaudenon‐Huibregtse United States	7	133 0.4×	411 1.6×	137 1.2×	64 1.0×	22 0.4×	9	469
Maryse Brassard France	7	123 0.4×	320 1.3×	54 0.5×	45 0.7×	37 0.6×	10	390

Countries citing papers authored by Mary Levin

Since Specialization

Citations

This map shows the geographic impact of Mary Levin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mary Levin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mary Levin more than expected).

Fields of papers citing papers by Mary Levin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mary Levin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mary Levin. The network helps show where Mary Levin may publish in the future.

Co-authorship network of co-authors of Mary Levin

This figure shows the co-authorship network connecting the top 25 collaborators of Mary Levin. A scholar is included among the top collaborators of Mary Levin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mary Levin. Mary Levin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

Kim, Teresa S., et al.. (2022). Effect of Touch Preparations on Tissue Adequacy for Ancillary Testing of Transthoracic Core Needle Biopsies. Journal of the American Society of Cytopathology. 11(6). S47–S48.

Zhu, Catherine, Chi‐Hong Tseng, Sung‐Eun Yang, et al.. (2020). Trends in the Surgical Management of Known or Suspected Differentiated Thyroid Cancer at a Single Institution, 2010–2018. Thyroid. 30(11). 1639–1645. 15 indexed citations

Livhits, Masha J., Catherine Zhu, Eric J. Kuo, et al.. (2020). Effectiveness of Molecular Testing Techniques for Diagnosis of Indeterminate Thyroid Nodules. JAMA Oncology. 7(1). 70–70. 114 indexed citations

Rao, Jianyu, et al.. (2018). Irrigation after Laparoscopic Power Morcellation and the Dispersal of Leiomyoma Cells: A Pilot Study. Journal of Minimally Invasive Gynecology. 25(4). 632–637. 11 indexed citations

Livhits, Masha J., Eric J. Kuo, Angela M. Leung, et al.. (2018). Gene Expression Classifier vs Targeted Next-Generation Sequencing in the Management of Indeterminate Thyroid Nodules. The Journal of Clinical Endocrinology & Metabolism. 103(6). 2261–2268. 38 indexed citations

Wu, James X., Raymond W. Lam, Mary Levin, et al.. (2015). Effect of malignancy rates on cost-effectiveness of routine gene expression classifier testing for indeterminate thyroid nodules. Surgery. 159(1). 118–129. 46 indexed citations

Yang, Sung‐Eun, Peggy Sullivan, Jianhua Zhang, et al.. (2015). Has Afirma gene expression classifier testing refined the indeterminate thyroid category in cytology?. Cancer Cytopathology. 124(2). 100–109. 48 indexed citations

Smith, Elaine, et al.. (2015). Comparative study of ProEx C immunocytochemistry and UroVysion fluorescent in-situ hybridization assays on urine cytology specimens. CytoJournal. 12. 2–2. 8 indexed citations

Rao, Jianyu, et al.. (2014). Comparative Evaluation of ProEx C and ImmunoCyt/uCyt Assays in Atypical Urine Cytology. Archives of Pathology & Laboratory Medicine. 138(9). 1215–1222. 7 indexed citations

10.

Moatamed, Neda A., et al.. (2013). ProExC as an adjunct marker to improve cytological detection of urothelial carcinoma in urinary specimens. Cancer Cytopathology. 121(6). 320–328. 14 indexed citations

11.

Moatamed, Neda A., et al.. (2011). In Papanicolaou smears, benign appearing endometrial cells bear no significance in predicting uterine endometrial adenocarcinomas. Diagnostic Cytopathology. 41(4). 335–341. 5 indexed citations

12.

Sullivan, Peggy, et al.. (2010). Urine cytology and adjunct markers for detection and surveillance of bladder cancer.. PubMed. 2(4). 412–40. 101 indexed citations

13.

Sullivan, Peggy, et al.. (2009). Comparison of ImmunoCyt, UroVysion, and urine cytology in detection of recurrent urothelial carcinoma. Cancer Cytopathology. 117(3). 167–173. 51 indexed citations

14.

Perlman, Max & Mary Levin. (1974). Fetal pulmonary hypoplasia, anuria, and oligohydramnios: Clinicopathologic observations and review of the literature. American Journal of Obstetrics and Gynecology. 118(8). 1119–1123. 50 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact